anti-CD26 antibody (Jiangsu ZonHon Biopharma Institute)

N/A

Report date: 2025/03/14 16:25:10

Base Information

Drug Nameanti-CD26 antibody (Jiangsu ZonHon Biopharma Institute)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionDipeptidyl peptidase IV inhibitors
TargetsDipeptidyl peptidase IV
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesZonhon Biopharma Institute Inc
China Registration ClassN/A

Develop Information

Active CompaniesZonhon Biopharma Institute Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A